SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Remedy Taking a hit why?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: seth thomas who wrote (63)1/28/1997 12:18:00 AM
From: Neurogenesis   of 763
 
I do appreciate your input, and the fact that you are willing to devote the time to answer my queries/assertions thoughtfully.

No, I would never blast you in public; although I'm sure you could 'take it', I don't have the ammunition!

I believe that I originally misrepresented the product referred to (more than I thought possible) by mentioning that it is competitive/synergistic with Remedy-type products. I did try to clarify that later (no pun intended).

The Global Maintech product has a wide range of functionality and POTENTIAL applications, one of which, the internal help desk function, has potential overlap with Remedy et al. However, as this is not their primary thrust, I do not consider them a competitor. Global is 100x more likely to team with Remedy than to try to compete against them.

I would definitely not invest in any start up which proposed to go after Remedy's market, regardless of the purported strength of their product.

I do note that CLFY, RMDY, VNTV, and SCOP, trade at multiples to earnings of (respectively) 120, 100, 75, and 103. Pricey, to say the least!

Now, if I am right (a big "if" or a small "if", I leave that up to you) three things are true:

- Global Maintech has a unique and advantageous paradigm for controlling, operating, and monitoring events throughout the 'Enterprise', as demonstrated by their current list of (very happy) customers. (read: paradigm shift)

- Global Maintech will hit their published earnings estimates, and bring down about $0.25/share for fiscal (calander) '97.

- Having purchased my stock between $0.50 and $1.50, applying only a fraction of the multiples noted for the above means that I should do fairly well; certainly better than I would/could do by buying anything that already trades at near or above 100x earnings, regardless of how fast these continue to grow.

If you want me to discuss my perception of the 'paradigm shift', I will be more than happy to do so. However, you are obviously a very intelligent software investor, and I don't want to bore you with things you may have no interest in.

Thanks again for your response.

Best Regards, Steve

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext